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I explain here why all scientists should feel obligated to do their part to support the community by
advocating for the benefits of government investments in scientific research and training.The work of most biological scientists
depends heavily on governmental fund-
ing, and this support stands in competi-
tion with every other program that
receives government funds. Historically,
biologists took for granted that politicians
would provide adequate funding, given
the virtue of advancing human health.
Complacency was the norm because the
budgets of the National Institutes of
Health (NIH) and National Science Foun-
dation (NSF) generally increased at or
above the level of inflation during the
second half of the 20th century, and the
budget of the NIH doubled between
1998 and 2003. Unfortunately, funding
has stagnated since 2003, so taking infla-
tion into account, the purchasing power of
the NIH budget has declined about 20%
over the last decade (AAAS, 2012;
also see http://www.aaas.org/spp/rd/ for
regular updates.)
Times have changed for the worse for
two reasons. First, the global economic
recession has done real damage to
science. Weak tax revenues and growing
deficits have led politicians to compro-
mise funding for research in spite of the
established benefit of basic research for
stimulating economic growth. The situa-
tion in the United States for 2013 is partic-
ularly dire. The failure of Congress to
adopt a deficit reduction program in
2011 resulted in a fall-back option called
sequestration, which may reduce federal
funding across the board by 8% on
January 1, 2013. If this comes to pass,
we face widespread unemployment in
the biological research community and
the loss of many valuable researchprograms. Second, although US citizens
still hold science and scientists in high
esteem (Masci, 2009), some politicians
use ideological opposition to scientific
findings (evolution and climate change to
cite two examples) to take anti-science
positions.
In our present situation, advocacy for
support of science must be a priority,
perhaps even an obligation, for every biol-
ogist. Our community must take responsi-
bility to convince politicians that funding
biomedical research will benefit not only
human health, but also our economic
well being. The objective of advocacy for
biomedical research is to help elected
officials focus on the merits of our work,
which is quite different from partisan poli-
tics. Voting and participation in electoral
politics are separate obligations of citi-
zens in a democracy.
Who Makes Decisions about
Science Funding?
The US Congress decides how much
money to appropriate for all federal
programs (Box 1). Very few scientists
hold elected positions at either the state
or national level. For example, the 112th
US Congress (2011–2012) includes four
scientists (all in the House of Representa-
tives) and 24 MDs (5 in the Senate and 19
in the House). They are outnumbered by
200 lawyers (52 in the Senate and 148 in
the House) and 209 businesspeople (28
in the Senate and 181 in the House) (CQ
Roll Call, 2010).
Consequently, members of the US
Congress have a low level of technical
and scientific expertise. Most lawmakersCell 151admire scientists, and many are even
apologetic about not having studied
science since high school or an introduc-
tory course in college. Without scientific
training, they are prone to distraction by
the many other interests clamoring for
their time and support. Among recent
presidents, Barack Obama is the most
supportive of science, but we are short
of science champions in the current
Congress.
Who Advocates for Federal Funds?
Advocates are an integral part of the legis-
lative process in Washington. Advocacy
by individuals and organizations is the
norm, and these diverse voices have
powerful influences on setting priorities
for all forms of government spending.
This practice is less common outside of
the US, or at least less exposed in public.
The powerful, self-interested advocates in
the US include defense contractors, oil
companies, banks, insurance companies,
churches, gun control groups, gun rights
groups, large and small businesses,
education, labor unions, transportation
companies, agriculture, casinos, universi-
ties, medical schools, doctors, construc-
tion companies, arts organizations, senior
citizens, and a long list of other lobbies.
Groups with deep pockets employ teams
of paid lobbyists to spread their message.
Politicians must get elected, and
financing a run for office is an integral
though sometimes unsettling aspect of
campaigns. Campaign contributions can
buy influence, given the money to run
a campaign (on average, more than $1
million to win a seat in the House and, October 12, 2012 ª2012 Elsevier Inc. 239
almost $10million to win in the Senate). By
law, not-for-profit organizations cannot
campaign for candidates or make political
contributions. However, virtually every
organization benefitting from federal or
state funding lobbies elected officials,
and those allowed to contribute (some-
times vast) sums to election campaigns
at the state andnational level. If the organi-
zation’s agenda aligns much more closely
with one of the major political parties than
the other, their support can become
a partisan issue, rather than a nonpartisan
issue. Think of gun rights and the Repub-
lican party (R) or labor unions and theBox 1. The Pathways of Actions Required to
Left Pathway. The Steps by the Federal Govern
Federal appropriations in the US are made annu
after each national election. The first three steps
end of the fiscal year, September 30, owing to
(1) The White House Office of Management and
ents to Congress as a proposed budget. The fed
President’s budget. External advocates can also
with assurance that Congress will improve the
(2) The House and Senate Budget Committees
among the large subdivisions of government suc
has the Presidency and controls the two house
creating their own budgets. These budgets pu
division of total spending, but ideology usually
(3) All appropriations bills originate in the Hous
divide their total spending allotment established
agencies as well as external advocates. Indivi
outcomes. Committee chairs have considerabl
to be spent, so each program requires support
(4) Full appropriations committees review subc
(5) Members of the House and Senate debate, a
appropriations bills, given that few of them serve
the end of the fiscal year, they approve one or m
sometimes stretching to months. These delays
operate. This uncertainty can delay funding of
(6) Appropriations bills from the House and Sena
Conference Committee to reconcile the bills (h
these conference committees can strongly infl
both houses.
(7) Both houses vote to approve the compromi
(8) The President then signs or vetoes the entir
(9) Agencies divide their appropriations amon
programs mandated in the appropriation bill.
Right Pathway. The Steps in Funding a Grant b
The internal review process differs at NSF, but o
assigned to an Institute and Initial Review Group
Institute staff and Council before (e) funds are
supplies, equipment, services, etc. required to
1In the current session of Congress, appropriati
are Representative Harold Rogers (R, KY) and S
Justice, Science, and Related Agencies (respon
MD). The chairs of the Appropriations Subcomm
NIH) are Representative Denny Rehberg (R, MT
appropriations.house.gov/ and http://www.app
240 Cell 151, October 12, 2012 ª2012 ElseviDemocratic party (D). Many organizations
contribute to opposing candidates in an
election, hoping that the winner will
support their causes.
Why Are Scientists on the
Sidelines?
In spite of being highly educated and
seeking support for a worthy cause,
scientists as a group are among the least
engaged in advocacy. Some scientists
are complacent because they live and
work in an urban center with a major
educational institution that is already rep-
resented by a highly supportive memberFund a Research Grant by the Federal Gover
ment to Appropriate Funds
ally, so each step is required every year. Congress
take place reliably in the winter and early spring, bu
disagreements within and between the two houses
Budget assembles a financial plan for the entire fe
eral agencies advocate for themselves inside the e
work with the administration on this plan. Presiden
appropriation.
create their own budget proposals, setting a tota
h asDefense, Health andHuman Services, Transpo
s of Congress, these budget committees may build
t overall constraints on federal expenditures. Exter
predominates at this stage.
e. Subcommittees of the appropriations committee
by their Budget Committees. At hearings, they rec
duals and groups also work behind the scenes wi
e influence in drafting appropriation bills that may
from these individuals.1
ommittee bills before sending them for considerati
mend, and vote on appropriation bills. This is the m
on appropriations committees or subcommittees.
ore ‘‘continuing resolutions’’ to fund agencies at th
are awkward for the funding agencies because they
specific grants and programs.
te are never identical, so the next step is for powerf
ttp://en.wikipedia.org/wiki/United_States_congres
uence appropriations at this step, emphasizing th
se bill.
e bill. If vetoed, the bill goes back to Congress.
g their programs, taking into account restrictions
y NIH
ther steps are similar to NIH. (a) The scientist writes
(study section), (c) reviewed by the IRG (with feedb
transferred to the applicant’s institution (f) to set u
do the research.
ons committees have the following leadership. The
enator Daniel K. Inouye (D, HI). The chairs of the Ap
sible for NSF) are Representative Frank R. Wolf (R, V
ittees on Labor, Health and Human Services, Educ
) and Senator Tom Harkin (D, IA). Other members
ropriations.senate.gov/.
er Inc.of the House of Representatives. Other
scientists are intimidated, feeling that
they would not know how to talk with an
elected official or his or her staff. Many
think that their single voice cannot make
a difference or that they lack the stature
to be effective. Some mentors deny their
trainees the opportunity to participate in
advocacy because they would miss time
from the lab. Other scientists feel that
advocating for science is unbecoming or
self-serving.
None of these excuses holds water.
Even if your House member supports
biomedical research, he or she needs tonment and by the NIH
ional committees are renewed every 2 years
t the later steps are often delayed beyond the
of Congress.
deral government, which the President pres-
xecutive branch during the formulation of the
ts often submit low budget proposals for NIH,
l level of spending and dividing that money
rtation, and so on. Depending onwhich party
upon or ignore the President’s budget when
nal advocates may attempt to influence this
s of the House and Senate consider how to
eive input from leaders of the various federal
th subcommittee staff to push for favorable
include stipulations about how the money is
on by their respective houses of Congress.
ain chance for most legislators to weigh in on
If Congress fails to pass appropriation bills by
e level of the previous year for a limited time,
do not know how much money they have to
ul lawmakers from both houses to form a joint
sional_conference_committee). Members of
e ongoing need for help from champions of
or specific funding allotments for specific
and submits a grant application, (b) which is
ack to the applicant), (d) and reviewed by the
p a research account to pay for personnel,
chairs of the Full Appropriations Committees
propriations Subcommittees on Commerce,
A) and Senator Barbara Mikulski (Democrat,
ation, and Related Agencies (responsible for
of these committees can be found at http://
be urged to become a champion for NIH
and NSF, and your two US Senators
may not be equally supportive and should
be contacted. Scientists usually have an
advantage in conversations with politi-
cians, who may be embarrassed by their
lack of scientific knowledge. Scientists,
especially youthful scientists, usually
make a positive impression on members
of Congress and their staff. No one should
be ashamed to promote funding of scien-
tific research. Discoveries in biology not
only drive improvements in healthcare,
but also benefit the economy. For
example, the $3.8 billion investment in
the Human Genome Project between
1988 and 2003 has been estimated to
generate $796 billion in economic activity
in the US between 1988 and 2010 (Gitlin,
2011). Even the lowest estimates of
economic return from government invest-
ments in NIH are in the range of 2 to 1 (Ehr-
lich, 2011). Universities that are depen-
dent on research support from NIH and
NSF are the largest employers in commu-
nities from Tucson, Arizona to Little Rock,
Arkansas to New Haven, Connecticut. So
many regional economies benefit from
investments in research.Who Advocates for Biomedical
Research?
Themost powerful advocates for biomed-
ical research in theUSare voluntary health
organizations such as American Cancer
Society, American Heart Association,
and Juvenile Diabetes Association. Their
volunteer members and professional
staffs are passionate about particular
diseases. They tend to be highly focused
on short-term advances in treatments
that can help their families and friends,
but some appreciate that a lack of funda-
mental knowledge is commonly the
limiting factor in advancing treatments.
Research!America is the leading volunteer
organization advocating broadly for
biomedical research. They keep track of
public opinion and publicize the broad
public support of biomedical research.
Prior to 1990, few scientific societies
tookpolitical positionsor lobbied for funds.
They left advocacy to the leaders of their
institutions, who worked through their
professional organizations, Association of
American Universities (AAU, the leading
research universities) and American Asso-
ciation of Medical Colleges (AAMC,
medical schools). Both organizationsCell 151have been effective advocates for policies
that allow their member institutions to be
successful, although their priorities can
differ from the members of their faculties.
Since 1990, most scientific societies
have developed active public policy
efforts, and some are well organized to
help their members be good advocates.
The pioneer in this effort was the Federa-
tion of Societies of Experimental Biology,
which for several decades has organized
an annual conference of their participating
societies to reach a consensus recom-
mendation for appropriations for the
federal science agencies. Another group
of societies formed an advocacy organi-
zation called Coalition for Life Sciences
(CLS). Since 1991, the Congressional
Biomedical Research Caucus sponsored
by CLS has hosted talks on Capitol Hill
by more than 275 biologists. Currently
this bipartisan Caucus has four cochairs:
Brian Bilbray (R, CA), Rush Holt (D, NJ),
Jackie Speier (D, CA), and Charlie Dent
(R, PA). In addition to hosting events,
Caucus leaders encourage their fellow
lawmakers inside and outside of the
Caucus to vote for legislation that is
essential for biomedical research., October 12, 2012 ª2012 Elsevier Inc. 241
Historically, science has been a nonpar-
tisan issue, with both Democrats and
Republicans serving as boosters for
research. Any legislation, particularly bills
that appropriate federal funds, requires
champions inside of Congress. Our
champion during the 1990s was Repre-
sentative John E. Porter (R, IL), who
chaired the appropriations committee
that funded NIH. He was recognized
with the Lasker Award for his contribu-
tions to biomedical research and is now
chairman of Research!America. During
the first decade of the current century,
Senator Arlen Spector (R, Pennsylvania)
looked out for NIH as a member of the
appropriations committee. Several times,
his personal intervention was essential for
increasing the appropriation for NIH, most
notably an extra $10 billion over 2 years
for NIH in the American Recovery and
Reinvestment Act of 2009. Neither of
these friends remains in Congress. Our
current champion is Senator Tom Harkin
(D, Iowa), but he needs help in the House
of Representatives. Without strong
support in both houses of Congress,
science budgets are unlikely to be
a priority during budget negotiations in
this tight fiscal year.
Call to Action
Given that the well being of biomedical
research depends on funding from the
federal government and given the stiff
competition for support from many other
groups that receive government funds,
every biologist should feel obliged by his
or her own self-interest and our worthy
cause to be an advocate for science.
Strong participation is particularly impor-
tant for young scientists, including grad-
uate students and postdocs, because
their futures depend on adequate funding.
The already competitive academic job
market and grant application process
will only worsen if funding continues to
decline in real dollars. Furthermore, young
people are remarkably effective advo-
cates. Politicians are used to older advo-
cates in suits and ties, so the appearance
of a group of enthusiastic grad students
and postdocs in a politician’s office will
be disarming and make a strong impres-
sion. Helping out is, of course, the right
thing to do, but young people should be
highly motivated to participate by self-
interest, as their futures are at stake.242 Cell 151, October 12, 2012 ª2012 ElseviGetting involved is easy because
support is already in place to help scien-
tists to participate. Here are five obliga-
tions for every biologist to take seriously.
Obligation 1: Join a Professional
Society with an Advocacy Program
Your dues will not only give you access to
the society’s scientific, mentoring, and
placement programs, but will also help
to fund their public policy and advocacy
programs. National professional societies
exist in most areas of biology and virtually
every clinical specialty and subspecialty.
Some of the larger basic science societies
are American Physiological Society,
American Society for Biochemistry and
Molecular Biology, American Society for
Cell Biology, American Society for Micro-
biology, American Society for Pharma-
cology and Experimental Therapeutics,
Biomedical Engineering Society, Bio-
physical Society, Genetics Society of
America, and Society for Neuroscience.
Many of these societies collaborate as
members of CLS and/or FASEB.
Obligation 2: Join Your Society’s
Grassroots Advocacy Network
Volunteer and respond to requests to
communicate with elected officials. Your
society will keep you up to date on the
status of important legislation and will
contact you when your voice needs to be
heard. When action is necessary, your
society will explain the issue and give you
a sample letter for you to customize with
information about you, your work, and
your concerns. Participation is open in
some biology advocacy groups, such as
the Congressional Liaison Committee
(CLC) of the Coalition for Life Sciences
(http://www.coalitionforlifesciences.org/).
You can join in the ‘‘other’’ category. Many
societies have software to help advocates
send e-mails to elected officials (and to
keep track of participation). Paper letters
to local congressional offices can also be
helpful, but getting paper mail to Washing-
ton offices of Congress has been slow
since the anthrax attack in 2001. A tele-
phone call is another simple option, partic-
ularly if time is crucial. Youcan lookupyour
electedofficial’s telephonenumbers on the
web, and youmay be surprised to find that
a pleasant, interested staff member takes
your call and registers your message.
Many scientists assume that their
communications with elected officials
will be a drop in the bucket and will noter Inc.count for much. However, even a very
small number of letters/e-mails can have
an impact. Five or ten letters will definitely
be noticed. Fifty letters or calls to one
office will have a huge impact. Your
friends in your department could generate
that many letters.
Obligation 3: Volunteer to Help Your
Society with Advocacy
One especially important task is to recruit
labmates, parents, and friends to join
grassrootsnetworks. Ifyouareaprofessor,
encourage your students, postdocs, and
technical staff to get involved. The small
amount of time that they will spend on
advocacy will be a good investment and
might even make a difference in getting
funds for the lab.
Enlisting relatives and friends as advo-
cates is particularly important for scien-
tistsworking in urbanareas,whereelected
officials are oftencommitted to supporting
science. On the other hand, the politicians
in one’s suburban or rural hometown
without a major educational institution in
the district may have never heard from
a scientist. The contrast in scientific advo-
cacy between urban and rural areas is
striking. For example, in 2011, CLC
members in California, New York, Penn-
sylvania, Illinois, Massachusetts, and
Connecticut sent between at total of
3,000 letters to lawmakers, whereas the
total number of letters to politicians in
Nevada, Alaska, Arizona, Delaware,
Idaho, Maine, Mississippi, New Mexico,
North Dakota, South Dakota, and Wyom-
ing was less than 75. These states with
little activity are vital to our cause because
each one has two US Senators. The rela-
tives of a couple of biologists in each one
of these states could make a difference.
Obligation 4: Visit Your Elected
Officials at Home or in Washington,
DC
Many societies hold organized Capitol Hill
Days, where groups of scientists visit
a number of Congressional offices. Often
the scientists will meet with staff assigned
to health or science affairs, but often the
Representative or Senator will join the
conversation. Each participant will take
1–2 min to introduce themselves and their
work to start the conversation. Your
enthusiasm about your work and your
concerns about federal funding will
register whether you see staff or the
lawmaker. When you return to the lab,
you can use the energy gained from your
visit to Congress to motivate your friends
and colleagues.
Elections are always on the minds of
lawmakers, so they are attentive to
constituents. You can visit their local
offices to explain your work and your
personal concerns. Many societies will
help to arrange a visit to the local office
of your Representative and Senators,
but a simple telephone call will result in
an appointment in many cases. Take
along five or six friends and colleagues
of all ages. Explain why the lawmaker’s
active support for science is important to
you, your institution, and your community.
They will be particularly interested in how
the competition for federal grants impacts
employment in their district.
Obligation 5: Let Elected Officials
Know about Funding of Grant
Applications
This powerful idea proposed by Larry
Goldstein (Goldstein, 2010) creates a
missing feedback loop in the system,
where we depend on the support of politi-
cians for funding but essentially never let
them know the outcomes of our requests
for funds. Every applicant for federal funds
should thank their elected officials when
a grant is funded, or, if the application is
not funded, one should politely explain
the effort put into the application and the
impact of the lack of funds on the research
and employment in the laboratory.
Opening the eyes of elected officials to
the local consequences of declining
federal funds may make them more likely
to support appropriations in the future. I
hope that the grants and contract offices
in each of our institutions can help faculty
make this feedback loop a routine part of
the federal funding process.
Other Opportunities
Vote for and Support Political
Candidates Who Appreciate the
Value of Science in our Society
Researchers should be aware of elections
for the US House of Representatives and
US Senate. The candidates’ websites,
voting records, and speeches will usually
reveal their positions on federal fundingof scientific research. If not, one can
attend a town hall meeting or political
event and ask candidates directly about
their positions. Participation is important
because a question from a scientist will
remind politicians that most voters
support federal funding for biomedical
research. Private citizens are allowed to
contribute to political campaigns locally
and nationally, including those of the few
scientists in Congress and the champions
of federal research funding. After the elec-
tion, scientists should encourage their
Representative to join the Biomedical
Research Caucus. A list of current
members can be found at http://www.
coalitionforlifesciences.org/. (Note that,
by traditions in Congress, some of our
strongest supporters do not participate
in caucuses, owing to their service on
budget or appropriations committees.)
Community Outreach
The general public also needs to hear
more about the value of science in
society, so scientists should take every
opportunity to participate in ‘‘Science
Cafe´s’’ (http://www.sciencecafes.org/) or
speaking opportunities to alumni groups
or local service clubs. Running a Science
Cafe´ requires some work, but they are
remarkably popular. We have one in my
town (http://www.tildecafe.org/). Another
opportunity is to author anop-edor a letter
to the editor in your local newspaper. One
type would point out the benefits of
federal science funding in your commu-
nity, as taxpayers appreciate knowing
that their taxes are being used for good
purposes. Other submissions could thank
local politicians for voting for increases in
science funding or explain the local
impact of poor appropriations. The staff
of your scientific society can help.
Invite Elected Officials to Visit Your
Laboratory
Visits from politicians are exciting but
require coordination with your institutional
leadership, whomay feel that it is inappro-
priate for a faculty member to offer such
an invitation. Therefore, consult with the
leadership of your institution and your
governmental affairs office before pro-
posing a visit to a politician.Cell 151A Career in Science Policy
Scientists who are interested in a career in
science policy have attractive options.
One is to spend 2 years in Washington,
DC as a Science and Technology Fellow.
The American Association for the
Advancement of Science manages this
highly influential program in partnership
withmore than 30science andengineering
societies (http://fellowships.aaas.org/).
Over the past 40 years, more than 2,000
scientists and engineers have participated
as AAAS Fellows by working in Congress
or a federal agency. Scientific expertise
provided by these fellows directly influ-
ences attitudes and legislation. Some
fellows return to the lab, but many use
the fellowship to launch exciting careers
ingovernment,NationalResearchCouncil,
scientific societies, voluntary health orga-
nizations, or advocacy. Many of these
organizations also offer internships or
fellowships to help individuals get started.ACKNOWLEDGMENTS
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